Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Two commonly used models of hepatic drug clearance are examined. The “well-stirred” model (model I) views the liver as a well-stirred compartment with concentration of drug in the liver in equilibrium with that in the emergent blood. The “parallel tube” model (model II) regards the liver as a series of parallel tubes with enzymes distributed evenly around the tubes and the concentration of drug declines along the length of the tube. Both models are examined under steady-state considerations in the absence of diffusional limitations (cell membranes do not limit the movement of drug molecules). Equations involving the determinants of hepatic drug clearance (hepatic blood flow, fraction of drug in blood unbound, and the hepatocellular enzymatic activity) and various pharmacokinetic parameters are derived. Similarities and differences between the models are explored. Although both models predict similar hepatic drug clearances under a variety of conditions, marked differences between them become apparent in their predictions of the influence of changes in the determinants of drug clearance on various pharmacokinetic parameters.
- E. Möller, J. R. McIntosh, and D. D. Van Slyke. Studies of urea excretion.J. Clin. Invest. 6:427–465 (1929).
- P. A. Shore, B. B. Brodie, and C. A. M. Hogben. The gastric secretion of drugs: A pH partition hypothesis.J. Pharmacol. Exp. Ther. 119:361–369 (1957).
- H. O. Heinemann and A. P. Fishman. Nonrespiratory function of the mammalian lung.Physiol. Rev. 49:1–47 (1969).
- M. Rowland, S. Riegelman, P. A. Harris, and S. D. Sholkoff. Absorption kinetics of aspirin in man following oral administration of an aqueous solution.J. Pharm. Sci. 61:379–385 (1972).
- J. G. Wagner, J. I. Northam, C. D. Alway, and O. S. Carpenter. Blood levels of drug at the equilibrium state after multiple dosing.Nature 201:1301–1302 (1965).
- M. Gibaldi, R. N. Boyes, and S. Feldman. Influence of first pass effect on availability of drugs.J. Pharm. Sci. 60:1338–1340 (1971).
- M. Rowland. The influence of route of administration on drug availability.J. Pharm. Sci. 61:70–74 (1972).
- P. D. Berk, T. F. Blaschke, and J. G. Waggoner. Defective bromosulphthalein clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome).Gastroenterology 63:472–481 (1972).
- G. R. Wilkinson. Pharmacokinetics of drug dispostion: Hemodynamic considerations.Ann Rev. Pharmacol. 15:11–27 (1975).
- M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1:123–136 (1973).
- D. G. Shand and R. E. Rangno. The disposition of propranolol. I. Elimination during oral absorption in man.Pharmacology 7:159–168 (1972).
- R. N. Boyes, H. J. Adams, and B. R. Duce. Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs.J. Pharmacol. Exp. Ther. 174:1–9 (1970).
- R. L. Wolen, C. M. Gruber, Jr., G. F. Kiplinger, and N. E. Scholz. Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.Toxicol. Appl. Pharmacol. 19:480–492 (1971).
- R. A. Branch, D. G. Shand, G. R. Wilkinson, and A. S. Nies. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey.J. Clin. Invest. 53:1101–1107 (1974).
- R. W. Brauer, G. F. Leong, R. F. McElroy, Jr., and R. J. Holloway. Circulatory pathways in the rat liver as revealed by P32 chromic phosphate colloid uptake in the isolated perfused liver preparation.Am. J. Physiol. 184:593–598 (1956).
- G. R. Wilkinson and D. G. Shand. Commentary: A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).
- G. Levy and A. Yacobi. Effect of protein binding on the elimination of warfarin.J. Pharm. Sci. 63:805–806 (1974).
- K. Winkler, S. Keiding, and N. Tygstrup. Clearance as a quantitative measure of liver function. In P. Paumgartner and R. Presig (eds.),The Liver: Quantitative Aspects of Structure and Functions, Karger, Basel, 1973, pp. 144–155.
- K. Winkler, L. Bass, S. Keiding, and N. Tygstrup. The effect of hepatic perfusion on assessment of kinetic constants. In F. Lundquist and N. Tygstrup (eds.),Alfred Benson Symposium VI: Regulation of Hepatic Metabolism, Munksgaard, Copenhagen, 1974, pp. 797–807.
- J. R. Gillette. Other aspects of pharmacokinetics. In J. R. Gillette and J. R. Mitchell (eds.),Concepts in Biochemical Pharmacology, Part 3, Springer-Verlag, New York, 1975, pp. 35–85.
- C. V. Greenway and R. D. Stark. Hepatic vascular beds.Physiol. Rev. 51:23–65 (1971).
- L. Bass, S. Keiding, K. Winkler, and N. Tygstrup. Enzymatic elimination of substrates flowing through the intact liver.J. Theor. Biol. 61:393–409 (1976).
- C. A. Goresky and H. L. Goldsmith. Capilliary-tissue exchange kinetics: Diffusional interactions between adjacent capillaries.Adv. Exp. Biol. Med. 37B:773–781 (1973).
- S. Keiding, S. Johansen, K. Winkler, K. Tønnesen, and N. Tygstrup. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig iiver.Am. J. Physiol. 230:1302–1313 (1976).
- R. A. Branch, A. S. Nies, and D. G. Shand. The disposition of propranolol. VIII. General implication of the effects of liver blood flow in elimination from the perfused rat liver.Drug Metab. Disp. 1:687–690 (1973).
- D. G. Shand, D. M. Kernhauser, and G. R. Wilkinson. Effects of route of administration and blood flow on hepatic drug elimination.J. Pharmacol. Exp. Ther. 195:424–432 (1975).
- D. Perrier and M. Gibaldi. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.J. Pharmacol. Exp. Ther. 191:17–24 (1974).
- D. G. Shand, R. H. Cotham, and G. R. Wilkinson. Perfusion-limited effects of plasma drug binding on hepatic drug extraction.Life Sci. 19:125–130 (1976).
- G. R. Wilkinson. Pharmacokinetics in disease states modifying body perfusion. In L. Z. Benet (ed.),The Effect of Disease States on Drug Pharmacokinetics, American Pharmaceutical Association of Pharmaceutical Sciences, Washington, D.C., 1976, pp. 13–22.
- A. Fischer. Dynamics of the circulation of the liver. In C. Rouiller (ed.),The Liver, Vol. I, Academic Press, New York, 1963, pp. 329–378.
- B. D. Ross.Perfusion Techniques in Biochemistry: A Laboratory Manual, Clarendon Press, Oxford, 1972.
- J. W. Culbertson, R. W. Wilkins, F. J. Ingelfinger, and S. E. Bradley. The effect of upright position upon the hepatic blood flow.J. Clin. Invest. 30:305–311 (1951).
- R. E. Stenson, R. T. Constantino, and D. C. Harrison. Interrelationships of hepatic blood flow, cardiac output and blood levels of lidocaine in man.Circulation 43:205–211 (1971).
- K. S. Pang and M. Rowland. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation.J. Pharmacokin. Biopharm. 5:655–680 (1977).
- T. L. Whitsett, P. G. Dayton, and J. L. McNay. The effect of hepatic blood flow on the hepatic removal of oxyphenbutazone in the dog.J. Pharmacol. Exp. Ther. 177:246–255 (1971).
- M. A. Gonzalez, T. N. Tozer, and D. T. T. Chang. Nonlinear tissue disposition: Salicylic acid in rat brain.J. Pharm. Sci. 64:99–103 (1975).
- E. R. Garrett and C. A. Hunt. Physicochemical properties, solubility, and protein binding of Δ9-tetrahydrocannabinol.J. Pharm. Sci. 63:1054–1064 (1974).
- S. Keiding. Hepatic elimination kinetics: The influence of hepatic blood flow on clearance determinations.Scand. J. Clin. Lab. Invest. 36:113–118 (1976).
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
Journal of Pharmacokinetics and Biopharmaceutics
Volume 5, Issue 6 , pp 625-653
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- hepatic drug clearance
- blood flow
- drug binding
- hepatocelluSar enzymatic activity
- intrinsic clearance
- Industry Sectors